tumorsMalignant tumoursMalignant tumours2224-50572587-6813Rosoncoweb10.18027/2224-5057-2023-13-3-5-7tumors-1162Research ArticleПИСЬМО В РЕДАКЦИЮLETTER TO THE EDITORКомментарий к публикации Яргунина С.А. и соавт. «Динамика изменений тумор-ассоциированных макрофагов у пациентов с первичной меланомой кожи в зависимости от способа хирургического лечения»Commentary on the publication of Yargunin S.A. et al. “Dynamics of changes in tumor-associated macrophages in patients with primary skin melanoma depending on the method of surgical treatment”ПетенкоН. Н.ПетенкоН. Н.
Н. Н. Петенко
Москва
n.petenko@ronc.ruКузьменкоА. О.КузьменкоА. О.
А. О. Кузьменко
Москва
СамойленкоИ. В.СамойленкоИ. В.
И. В. Самойленко
Москва
ФГБУ «НМИЦ онкологии им. Н.Н. Блохина» Минздрава РоссииRussian Federation20230811202313357Copyright © Петенко Н.Н., Кузьменко А.О., Самойленко И.В., 20232023Петенко Н.Н., Кузьменко А.О., Самойленко И.В.Петенко Н.Н., Кузьменко А.О., Самойленко И.В.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.malignanttumors.org/jour/article/view/1162
.
.
ReferencesMacCormack MA, Cohen LM, Rogers GS : Local melanoma recurrence : a clarification of terminology. Dermatol Surg 2004, 30 (12 Pt 2) : 1533–1538.MacCormack MA, Cohen LM, Rogers GS : Local melanoma recurrence : a clarification of terminology. Dermatol Surg 2004, 30 (12 Pt 2) : 1533–1538.Heenan PJ, Ghaznawie M : The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg 1999, 52 (3) : 209–213.Heenan PJ, Ghaznawie M : The pathogenesis of local recurrence of melanoma at the primary excision site. Br J Plast Surg 1999, 52 (3) : 209–213.Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS : The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 1984, 200 (6) : 759–763.Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS : The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann Surg 1984, 200 (6) : 759–763.Bittar PG, Bittar JM, Etzkorn JR, Brewer JD, Aizman L, Shin TM, Sobanko JF, Higgins HW, Giordano CN, Cohen JV et al : Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision. J Am Acad Dermatol 2021, 85 (3) : 681–692.Bittar PG, Bittar JM, Etzkorn JR, Brewer JD, Aizman L, Shin TM, Sobanko JF, Higgins HW, Giordano CN, Cohen JV et al : Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision. J Am Acad Dermatol 2021, 85 (3) : 681–692.Барышников КА : Иссечение послеоперационных рубцов при меланоме кожи: можем ли мы отказаться от традиций?. In : Ежегодная конференция Ассоциации специалистов по проблемам меланомы «МЕЛАНОМА И ОПУХОЛИ КОЖИ 2023» 2013 ; Москва : НО «Ассоциации специалистов по проблемам меланомы»; 2013.Барышников КА : Иссечение послеоперационных рубцов при меланоме кожи: можем ли мы отказаться от традиций?. In : Ежегодная конференция Ассоциации специалистов по проблемам меланомы «МЕЛАНОМА И ОПУХОЛИ КОЖИ 2023» 2013 ; Москва : НО «Ассоциации специалистов по проблемам меланомы»; 2013.Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM et al : Prognostic factors analysis of 17,600 melanoma patients : validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19 (16) : 3622–3634.Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM et al : Prognostic factors analysis of 17,600 melanoma patients : validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001, 19 (16) : 3622–3634.Ascierto PA, Khattak MA, Merino LdlC, Vecchio MD, Rutkowski P, Spagnolo F, Mackiewicz J, Chiarion-Sileni V, Kirkwood JMM, Robert C et al : Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma : Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study. Journal of Clinical Oncology 2023, 41 (17_suppl) : LBA9505-LBA9505.Ascierto PA, Khattak MA, Merino LdlC, Vecchio MD, Rutkowski P, Spagnolo F, Mackiewicz J, Chiarion-Sileni V, Kirkwood JMM, Robert C et al : Pembrolizumab versus placebo as adjuvant therapy in stage IIB or IIC melanoma : Final analysis of distant metastasis-free survival in the phase 3 KEYNOTE-716 study. Journal of Clinical Oncology 2023, 41 (17_suppl) : LBA9505-LBA9505.Ackerman AB : Mythology and numerology in the sphere of melanoma. Cancer 2000, 88 (3) : 491–496.Ackerman AB : Mythology and numerology in the sphere of melanoma. Cancer 2000, 88 (3) : 491–496.Gastman BR, Gerami P, Kurley SJ, Cook RW, Leachman S, Vetto JT : Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol 2019, 80 (1) : 149–157 e144.Gastman BR, Gerami P, Kurley SJ, Cook RW, Leachman S, Vetto JT : Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria. J Am Acad Dermatol 2019, 80 (1) : 149–157 e144.
The authors declare that there are no conflicts of interest present.